ENTX 8-K 2026-11-06

Entera Bio Ltd. (ENTX) 8-K dated 2026-11-06 — accession 0001178913-26-005056.

Entera Bio Ltd. (ENTX) is a biotechnology company listed on US.

ENTX: Announces Third Quarter 2026 Financial Results and Business Updates

This 8-K covers: Results of operations (Item 2.02), Reg FD disclosure (Item 7.01), Exhibits (Item 9.01). SEC EDGAR holds the official filing and its exhibits.

Latest reported ENTX revenue for 2025-12-31 was $42.0K. Net income was -$11.4M. Revenue was down 76.8% from 2024-12-31 to 2025-12-31. ENTX currently screens at market cap $58.2M.

Not investment advice. The ENTX SEC hub lists recent forms. The stock page is the research view.